Item 1.01 Entry into a Material Definitive Agreement.

On March 31, 2023, Medpace Holdings, Inc., a Delaware corporation (the "Company"), through its wholly owned subsidiaries, Medpace, Inc., as borrower, and Medpace IntermediateCo, Inc., as guarantor, entered into Amendment No. 5 to Loan Documents ("Amendment No. 5") with PNC Bank, National Association in connection with the Company's unsecured credit facility (the "Loan Documents"). Amendment No. 5 changes the aggregate principal amount that may be borrowed under the facility's line of credit to up to $150 million, adjusts the interest rate and fee charged on the credit facility and extends the expiration date of the revolving credit note to March 29, 2024.

The foregoing description of Amendment No. 5 is qualified in its entirety by reference to Amendment No. 5. A copy of Amendment No. 5 is filed herewith as Exhibit 10.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits

   Exhibit No.           Description
       10.1                Amendment No. 5 dated March 31, 2023 to Loan Documents
       104               Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses